Article Published 16 Oct 2025 Understanding The EU's International Procurement Instrument China Government, Public Sector CM Crowell & Moring LLP
Article Published 15 Oct 2025 汉坤 • 观点 | 《药品管理法实施条例》(修订草案)重点快评 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 15 Oct 2025 汉坤 • 观点 | 中国药品年度报告制度简析 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 15 Oct 2025 汉坤 • 观点 | 简评新版《医疗器械临床试验质量管理规范(GCP)》 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 13 Oct 2025 Han Kun • Opinion | Interpretation Of The "Detailed Rules For The Supervision Of Internet Diagnosis And Treatment (Trial)" China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 13 Oct 2025 Han Kun • Opinion | Research On Urban Customized Commercial Medical Insurance China Insurance HK Han Kun Law Offices
Article Published 9 Oct 2025 汉坤 • 观点 | 医药BD项目如何友好"分手"? China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 How Digital Therapeutics (DTx) Products Are Regulated In China? China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 2024 Data Analytics: China Life Sciences NewCo & Licensing Terms China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 7 Oct 2025 Han Kun • Opinion | The New Ethical Review Regulations Focus On Quick Comments China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 7 Oct 2025 Han Kun • Opinion | Hainan Boao Lecheng Clinical Urgently Needs A Review Of The Highlights Of The New Regulations On The Management Of Imported Drugs And Devices China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 6 Oct 2025 Han Kun • Opinion | Brief Review Of The Measures For The Review Of Science And Technology Ethics (Trial) (Draft For Comments) China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 3 Oct 2025 汉坤 • 观点 | CAR-T/NK监管路在何方 — 体细胞临床研究工作指引(征求意见稿)要点解读 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 3 Oct 2025 Han Kun • Opinion | Implementation And Regulation Of DCT (Decentralized Clinical Trials) In China China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 3 Oct 2025 汉坤 • 观点 | LDT试点新规解读 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 2 Oct 2025 Han Kun • Opinion | The Spring Of Traditional Chinese Medicine? From The "Special Provisions On The Registration And Administration Of Traditional Chinese Medicines", The Characteristic Marketing Evaluation System Of Traditional Chinese Medicine China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 1 Oct 2025 药企出海新热点:管线分拆"SON"模式的实践解读 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 1 Oct 2025 Han Kun Opinion | Breaking News: 10 Questions And Answers On Pharmaceutical Anti-Corruption In 2023 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 1 Oct 2025 Han Kun Opinion | CAR-T/NK Regulatory Decisions — Interpreting The "Guidelines For Somatic Cell Clinical Research (Trial)" China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 29 Sep 2025 汉坤 • 观点 | 从药械产品全生命周期视角解读License-in/out许可交易项目合作条款要点 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices